• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by VSee Health Inc.

    12/18/25 6:37:18 AM ET
    $VSEE
    Medical/Nursing Services
    Health Care
    Get the next $VSEE alert in real time by email
    DEFA14A 1 vseedefa14a121725.htm FORM DEFA14A

     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

     

    Schedule 14A

     

     

     

    INFORMATION REQUIRED IN PROXY STATEMENT
    SCHEDULE 14A INFORMATION

     

    Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

     

    Filed by the Registrant ☒
       
    Filed by a party other than the Registrant  ☐

     

    Check the appropriate box:

     

    ☐ Preliminary Proxy Statement
       
    ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
       
    ☐ Definitive Proxy Statement
       
    ☒ Definitive Additional Materials
       
    ☐ Soliciting Material under § 240. 14a-12

     

    VSEE Health, Inc.

    (Name of Registrant as Specified In Its Charter)

     

     

    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

     

    Payment of Filing Fee (Check all boxes that apply):

     

    ☒ No fee required.
       
    ☐ Fee paid previously with preliminary materials.
       
    ☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

     

     

     

     

    SUPPLEMENT TO THE PROXY STATEMENT OF VSEE HEALTH, INC.
    FOR THE ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON DECEMBER 30, 2025

     

    On November 24, 2025, VSee Health, Inc. (“VSEE,” “we,” “us,” “our,” and the “Company”) filed a definitive proxy statement (the “Proxy Statement”) and the related proxy card (the “Proxy Card”) relating to the Company’s Annual Meeting of Stockholders originally to be held on Monday, December 15, 2025, which was subsequently postponed to Tuesday, December 30, 2025, via live webcast at the following address: https://www.cstproxy.com/vseehealth/2025 (the “Annual Meeting”).

     

    On December 17, 2025, the Board of Directors of the Company approved an amendment of the Company’s Amended and Restated Bylaws to reduce the quorum needed for stockholder meetings to one-third (33.33%) of the voting power of the shares of capital stock of the Company issued and outstanding and entitled to vote at a meeting of stockholders, present in person or represented by proxy. The quorum requirement was also applied retroactively to the Annual Meeting.

     

    The Company has also engaged D.F. King & Co., Inc. (“DF King”) to act as its proxy advisor and to assist the Company in soliciting proxies related to the proposals set forth in the Proxy Statement and to be voted upon at the Annual Meeting, and at any adjournments or postponements thereof. DF King may solicit proxies personally, electronically or by telephone. The Company has agreed to pay DF King $12,500, plus customary costs and expenses, for these services.

     

    If you have voted by proxy already, your vote will be counted – there is no need to take any further action. If for any reason you wish to revoke your proxy, please follow the instructions in the Proxy Statement for the Annual Meeting.

     

    This document supplements the Proxy Statement for the Annual Meeting, to reflect the new quorum requirement applicable to the Annual Meeting.

     

    Accordingly, the Proxy Statement is hereby supplemented as follows:

     

    ●The following text replaces, in its entirety, the disclosure under the heading “Quorum” on page 2 of the Proxy Statement:

     

    “Quorum

     

    A quorum of our stockholders is necessary to hold a valid meeting. The presence, in person (which includes presence virtually at the Annual Meeting) or by proxy of holders of one-third (33.33%) of the voting power of our outstanding shares of voting stock entitled to vote at the Annual Meeting will constitute a quorum. In the absence of a quorum, the chairperson of the Annual Meeting has the power to adjourn the Annual Meeting. As of the Record Date, shares of outstanding voting stock entitled to vote at the Annual Meeting representing 10,762,250 votes would be required to achieve a quorum.”

     

    ●The following text replaces, in its entirety, the disclosure under the heading “Proxy Solicitation Costs” on page 4 of the Proxy Statement:

     

    2

     

    “Proxy Solicitation Costs

     

    We are soliciting proxies on behalf of the Board of Directors. This solicitation is being made by mail but also may be made by telephone or in person. We, along with our directors, officers and employees, may also solicit proxies in person, by telephone or by other electronic means. We will bear the cost of the solicitation.

     

    We have also engaged D.F. King & Co., Inc. (“DF King”) to act as our proxy advisor and to assist us in soliciting proxies related to the proposals set forth herein and to be voted upon at the Annual Meeting, and at any adjournments or postponements thereof. DF King may solicit proxies personally, electronically or by telephone. We have agreed to pay DF King $12,500, plus customary costs and expenses, for these services.

     

    We will ask banks, brokers and other institutions, nominees and fiduciaries to forward the proxy materials to their principals and to obtain their authority to execute proxies and voting instructions. We will reimburse them for their reasonable expenses.”

     

    Except as described above, this supplement to the Proxy Statement does not modify, amend, supplement, or otherwise affect the Proxy Statement or the Proxy Card and they continue to be in full force and effect as originally filed and the Board of Directors continues to seek the vote of Company stockholders to be voted on at the Annual Meeting as recommended in the original filing. This supplement to the Proxy Statement does not provide all of the information that is important to your voting decisions at the Annual Meeting, and the Proxy Statement contains other important additional information. This supplement to the Proxy Statement should be read in conjunction with the Proxy Statement.

     

    If you have already voted, you do not need to vote again unless you would like to change or revoke your prior vote. If you would like to change or revoke your prior vote, please refer to page 1 in the Proxy Statement for instructions on how to do so.

     

    This supplement to the Proxy Statement does not change the proposals to be acted upon at the Annual Meeting, which are described in the Proxy Statement. As a stockholder, your vote is very important, and the Board encourages you to exercise your right to vote whether or not you plan to attend the Annual Meeting. If you have already voted by Internet or by mail, you do not need to take any action unless you wish to change your vote. Proxy voting instructions already returned by stockholders (via Internet or mail) will remain valid and will be voted at the Annual Meeting unless revoked.

     

    December 18, 2025

     

    3

    Get the next $VSEE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $VSEE

    DatePrice TargetRatingAnalyst
    2/24/2025$5.00Buy
    Maxim Group
    More analyst ratings

    $VSEE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Maxim Group initiated coverage on VSee Lab with a new price target

    Maxim Group initiated coverage of VSee Lab with a rating of Buy and set a new price target of $5.00

    2/24/25 8:42:03 AM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    $VSEE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    VSee New AI Doctor Notes Reduces Documentation Time 93% – Transforming Virtual Emergency Care for Tele911

    VSee Health, Inc. (NASDAQ:VSEE) a leading provider of secure digital health solutions, today announced the launch of its new AI doctor notes, one of the solutions in its AI solutions suite. VSee has partnered with Tele911, the largest national telemedicine emergency room diversion service, to integrate VSee's AI Doctor Notes into its virtual emergency care workflow. Emergency medicine demands rapid decision-making and high patient throughput. The integration has drastically reduced Tele911 physician's charting time by 93% from 15 minutes per visit to under 1 minute, potentially increasing physician visit capacity. This new VSee AI solution automatically transcribes visits and generates

    7/14/25 8:17:00 AM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    VSee Powers Groundbreaking NIH Stroke Recovery Study in Phase 3 Clinical Trial

    VSee Health, Inc. (NASDAQ:VSEE) a leading provider of HIPAA-compliant digital health solutions has been selected to support a NIH-funded Phase 3 clinical trial study on stroke recovery telerehabilitation based out of UCLA—the second such national trial of post-stroke telerehabilitation. The trial spans 29 hospitals and 202 patients, and will evaluate the outcomes of adding 6 weeks of gamified, home-based telerehab to improve arm functionality in stroke survivors while reducing costs like transportation, caregiver burdens, and hospital readmissions. The proven efficacy of Phase 3 trials opens doors for Medicare and private payer reimbursement and opportunities in the $328M global stroke re

    6/23/25 8:27:00 AM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    VSee Health, Inc. Receives Nasdaq Notice on Delayed Form 10-Q Filing

    VSee Health, Inc. (the "Company") (NASDAQ:VSEE), announced today that on May 23, 2025, the Company received a notice from The Nasdaq Stock Market LLC ("Nasdaq") stating that because the Company had not yet filed its Quarterly Report on Form 10-Q for the period ended March 31, 2025, and its Annual Report on Form 10-K for the period ended December 31, 2024, the Company is not in compliance with Nasdaq's listing rule 5250(c)(1), which requires timely filing of periodic financial reports with the Securities and Exchange Commission (the "SEC"). The Nasdaq notice has no immediate effect on the listing or trading of the Company's common stock or its public warrants on The Nasdaq Capital Market.

    5/30/25 4:07:00 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    $VSEE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $VSEE
    SEC Filings

    View All

    Large owner Digital Health Sponsor Llc disposed of 2,630,250 shares (SEC Form 4)

    4 - VSEE HEALTH, INC. (0001864531) (Issuer)

    12/4/25 6:27:27 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    Co-CEO Aisiku Imoigele disposed of 120,000 shares, decreasing direct ownership by 3% to 3,416,990 units (SEC Form 4)

    4 - VSEE HEALTH, INC. (0001864531) (Issuer)

    11/19/24 8:57:01 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    Large owner Sands Lawrence M. acquired $405,000 worth of shares (202,500 units at $2.00) (SEC Form 4)

    4 - VSEE HEALTH, INC. (0001864531) (Issuer)

    11/19/24 8:55:08 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    SEC Form DEFA14A filed by VSee Health Inc.

    DEFA14A - VSEE HEALTH, INC. (0001864531) (Filer)

    12/18/25 6:37:18 AM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    VSee Health Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

    8-K - VSEE HEALTH, INC. (0001864531) (Filer)

    12/18/25 6:31:27 AM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    VSee Health Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - VSEE HEALTH, INC. (0001864531) (Filer)

    12/12/25 4:31:15 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    $VSEE
    Financials

    Live finance-specific insights

    View All

    VSee Health Interview to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

    ORLANDO, FL / ACCESSWIRE / December 20, 2024 / RedChip Companies will air an interview with VSee Health, Inc. (NASDAQ:VSEE) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, December 21, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interview in its entirety at: https://www.redchip.com/assets/access/vsee_accessIn an exclusive interview, Milton Chen, PhD, co-CEO of VSee Health, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to share insight into how VSee Health's differentiated solutions position the company as a growing leader in the $787 billion telehealth

    12/20/24 9:00:00 AM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    VSee Health and 60 Degrees Pharmaceuticals Interviews Aired on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

    ORLANDO, FL / ACCESSWIRE / December 2, 2024 / RedChip Companies aired interviews with VSee Health, Inc. (NASDAQ:VSEE) and 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV on November 30. Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interviews in their entirety at:VSEE: https://www.redchip.com/assets/access/vsee_accessSXTP: https://www.redchip.com/assets/access/sxtp_accessIn an exclusive interview, Imo Aisiku, M.D., co-CEO and Chairman of VSee Health, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to share insight into how VSee Health's differentiated so

    12/2/24 4:05:00 PM ET
    $SXTP
    $VSEE
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical/Nursing Services

    $VSEE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by VSee Health Inc.

    SC 13G/A - VSEE HEALTH, INC. (0001864531) (Subject)

    11/14/24 8:45:14 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by VSee Health Inc.

    SC 13G/A - VSEE HEALTH, INC. (0001864531) (Subject)

    11/14/24 5:23:34 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G filed by VSee Health Inc.

    SC 13G - VSEE HEALTH, INC. (0001864531) (Subject)

    7/5/24 4:29:01 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care